Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	-	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	2.13e-05	679	145	17	3.30.160.60
Domain	KRAB	ZNF559 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZNF439 ZNF564 ZNF583 ZNF433	2.35e-05	358	145	12	PS50805
Domain	KRAB	ZNF559 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZNF439 ZNF564 ZNF583 ZNF433	2.35e-05	358	145	12	PF01352
Domain	zf-C2H2	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	2.76e-05	693	145	17	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	2.81e-05	694	145	17	IPR013087
Domain	KRAB	ZNF559 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZNF439 ZNF564 ZNF583 ZNF433	3.17e-05	369	145	12	SM00349
Domain	KRAB	ZNF559 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZNF439 ZNF564 ZNF583 ZNF433	3.25e-05	370	145	12	IPR001909
Domain	Znf_C2H2-like	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 RBM6 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	4.59e-05	796	145	18	IPR015880
Domain	ZnF_C2H2	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 RBM6 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	5.57e-05	808	145	18	SM00355
Domain	ZINC_FINGER_C2H2_2	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	1.10e-04	775	145	17	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	1.13e-04	777	145	17	PS00028
Domain	Znf_C2H2	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	1.73e-04	805	145	17	IPR007087
Domain	zf-C2H2_6	ZBTB16 PATZ1 ZNF184 ZNF224 ZNF182 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF433	1.74e-04	314	145	10	PF13912
Domain	Neurogenic_DUF	NEUROD4 NEUROD1	3.56e-04	4	145	2	IPR022575
Domain	Neuro_bHLH	NEUROD4 NEUROD1	3.56e-04	4	145	2	PF12533
Domain	TF_bHLH_NeuroD	NEUROD4 NEUROD1	3.56e-04	4	145	2	IPR016637
Pubmed	The chromatin-targeting protein Brd2 is required for neural tube closure and embryogenesis.	NEUROD4 NEUROD1 SLITRK6 MED26	1.06e-08	7	147	4	19362612
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK3 DAG1 DMD	7.35e-07	5	147	3	19109891
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	GINS3 UFSP2 ANK3 ZNF559 KAT6A DAG1 TRIM21 RRM1 SLC25A51 FAT1 NF1 TXNL4B KLHL13 LPXN NEIL3 TNXB ZNF583 FILIP1L	9.54e-06	1293	147	18	15342556
Pubmed	An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase.	NUP98 DAG1 SLC30A6 KHDRBS1 RBM6 PLEKHA7 USP6NL	1.22e-05	180	147	7	35198878
Pubmed	α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.	DAG1 DMD	1.77e-05	2	147	2	28572004
Pubmed	Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.	DAG1 DMD	1.77e-05	2	147	2	10932245
Pubmed	Disruption of sarcolemmal dystrophin and beta-dystroglycan may be a potential mechanism for myocardial dysfunction in severe sepsis.	DAG1 DMD	1.77e-05	2	147	2	20142806
Pubmed	Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells.	TET2 TDG	1.77e-05	2	147	2	34158086
Pubmed	TET2- and TDG-mediated changes are required for the acquisition of distinct histone modifications in divergent terminal differentiation of myeloid cells.	TET2 TDG	1.77e-05	2	147	2	28973458
Pubmed	A 1.4-Mb high-resolution physical map and contig of chromosome segment 11p15.5 and genes in the LOH11A metastasis suppressor region.	TRIM21 RRM1	1.77e-05	2	147	2	9933563
Pubmed	Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice.	DAG1 DMD	1.77e-05	2	147	2	7894483
Pubmed	The WW domain of dystrophin requires EF-hands region to interact with beta-dystroglycan.	DAG1 DMD	1.77e-05	2	147	2	10355629
Pubmed	Dystroglycan Mediates Clustering of Essential GABAergic Components in Cerebellar Purkinje Cells.	DAG1 DMD	1.77e-05	2	147	2	32982691
Pubmed	Lack of dystrophin leads to the selective loss of superior cervical ganglion neurons projecting to muscular targets in genetically dystrophic mdx mice.	DAG1 DMD	1.77e-05	2	147	2	16023353
Pubmed	SLC25A51 is a mammalian mitochondrial NAD+ transporter.	SLC25A51 SLC25A52	1.77e-05	2	147	2	32906142
Pubmed	What do mouse models of muscular dystrophy tell us about the DAPC and its components?	DAG1 DMD	1.77e-05	2	147	2	25270874
Pubmed	Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy.	TRPM6 INSR	1.77e-05	2	147	2	22733750
Pubmed	Preventing phosphorylation of dystroglycan ameliorates the dystrophic phenotype in mdx mouse.	DAG1 DMD	1.77e-05	2	147	2	22810924
Pubmed	Role of mental retardation-associated dystrophin-gene product Dp71 in excitatory synapse organization, synaptic plasticity and behavioral functions.	DAG1 DMD	1.77e-05	2	147	2	19649270
Pubmed	Reduced proliferative activity of primary POMGnT1-null myoblasts in vitro.	POMGNT1 DMD	1.77e-05	2	147	2	19114101
Pubmed	Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA.	TET2 TDG	1.77e-05	2	147	2	21817016
Pubmed	Exogenous Dp71 is a dominant negative competitor of dystrophin in skeletal muscle.	DAG1 DMD	1.77e-05	2	147	2	12398834
Pubmed	Functional implication of Dp71 in osmoregulation and vascular permeability of the retina.	DAG1 DMD	1.77e-05	2	147	2	19809515
Pubmed	Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.	DAG1 DMD	1.77e-05	2	147	2	7592992
Pubmed	Acquired resistance to dasatinib in lung cancer cell lines conferred by DDR2 gatekeeper mutation and NF1 loss.	DDR2 NF1	1.77e-05	2	147	2	24296828
Pubmed	A genome-wide scan of cleft lip triads identifies parent-of-origin interaction effects between ANK3 and maternal smoking, and between ARHGEF10 and alcohol consumption.	ANK3 ARHGEF10	1.77e-05	2	147	2	31372216
Pubmed	Dystroglycan contributes to the formation of multiple dystrophin-like complexes in brain.	DAG1 DMD	1.77e-05	2	147	2	11520903
Pubmed	Disorganized innervation and neuronal loss in the inner ear of Slitrk6-deficient mice.	POU4F1 NEUROD1 SLITRK6	2.60e-05	14	147	3	19936227
Pubmed	Integral bHLH factor regulation of cell cycle exit and RGC differentiation.	NEUROD4 POU4F1 NEUROD1	3.24e-05	15	147	3	29770538
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	NBEAL1 KAT6A SHMT2 SNX33 URGCP FAT1 P3H2 AMOTL1 LPXN NEIL3 CATSPERG MAN1B1	3.91e-05	689	147	12	36543142
Pubmed	BARHL2 differentially regulates the development of retinal amacrine and ganglion neurons.	NEUROD4 POU4F1 NEUROD1	3.98e-05	16	147	3	19339595
Pubmed	Coordinated regulation of gene expression by Brn3a in developing sensory ganglia.	NEUROD4 POU4F1 NEUROD1	4.82e-05	17	147	3	15253936
Pubmed	N-terminal α Dystroglycan (αDG-N): A Potential Serum Biomarker for Duchenne Muscular Dystrophy.	DAG1 DMD	5.31e-05	3	147	2	27854211
Pubmed	A new look at cytoskeletal NOS-1 and β-dystroglycan changes in developing muscle and brain in control and mdx dystrophic mice.	DAG1 DMD	5.31e-05	3	147	2	23940011
Pubmed	Utrophin A is essential in mediating the functional adaptations of mdx mouse muscle following chronic AMPK activation.	DAG1 DMD	5.31e-05	3	147	2	25324540
Pubmed	The mitochondrial NAD+ transporter SLC25A51 is a fasting-induced gene affecting SIRT3 functions.	SLC25A51 SLC25A52	5.31e-05	3	147	2	35932995
Pubmed	Dystroglycan is not required for localization of dystrophin, syntrophin, and neuronal nitric-oxide synthase at the sarcolemma but regulates integrin alpha 7B expression and caveolin-3 distribution.	DAG1 DMD	5.31e-05	3	147	2	11741881
Pubmed	Drastic reduction of sarcalumenin in Dp427 (dystrophin of 427 kDa)-deficient fibres indicates that abnormal calcium handling plays a key role in muscular dystrophy.	DAG1 DMD	5.31e-05	3	147	2	14678011
Pubmed	Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice.	DAG1 DMD	5.31e-05	3	147	2	1757468
Pubmed	Congenital hearing impairment associated with peripheral cochlear nerve dysmyelination in glycosylation-deficient muscular dystrophy.	POMGNT1 DMD	5.31e-05	3	147	2	32453729
Pubmed	Overexpression of EGFR in head and neck squamous cell carcinoma is associated with inactivation of SH3GL2 and CDC25A genes.	SH3GL2 CDC25A	5.31e-05	3	147	2	23675485
Pubmed	p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K.	INSR KHDRBS1	5.31e-05	3	147	2	10437794
Pubmed	Deletion of Galgt2 (B4Galnt2) reduces muscle growth in response to acute injury and increases muscle inflammation and pathology in dystrophin-deficient mice.	DAG1 DMD	5.31e-05	3	147	2	26435413
Pubmed	Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA.	TET2 TDG	5.31e-05	3	147	2	24838012
Pubmed	Postnatal DNA demethylation and its role in tissue maturation.	TET2 INSR	5.31e-05	3	147	2	29795194
Pubmed	Glycomic analyses of mouse models of congenital muscular dystrophy.	DAG1 POMGNT1	5.31e-05	3	147	2	21460210
Pubmed	Phosphorylation within the cysteine-rich region of dystrophin enhances its association with β-dystroglycan and identifies a potential novel therapeutic target for skeletal muscle wasting.	DAG1 DMD	5.31e-05	3	147	2	25082828
Pubmed	Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice.	INSR TIMP3	5.31e-05	3	147	2	19027012
Pubmed	Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.	DAG1 DMD	5.31e-05	3	147	2	8589441
Pubmed	Targeting Cul3-scaffold E3 ligase complex via KLHL substrate adaptors for cancer therapy.	KLHL9 KLHL13	5.31e-05	3	147	2	33872809
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	ADAMTS2 KIAA0586 DAG1 SHMT2 TDG ZNF224 SMYD4 ZNF182 FAT1 NF1 KHDRBS1 ARHGEF10 NEIL3 PLEKHA7 ZNF433 PRODH	5.96e-05	1215	147	16	15146197
Pubmed	Genes, plasticity and mental retardation.	RAB3GAP1 NF1 DMD	6.82e-05	19	147	3	18329113
Pubmed	Foxn4 controls the genesis of amacrine and horizontal cells by retinal progenitors.	NEUROD4 POU4F1 NEUROD1	6.82e-05	19	147	3	15363391
Pubmed	Zac1 functions through TGFbetaII to negatively regulate cell number in the developing retina.	NEUROD4 POU4F1 NEUROD1	9.30e-05	21	147	3	17559664
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	ANK3 GIT1 TBC1D2B APBB1 ARHGEF12 BIRC6 PLEKHA7	1.01e-04	251	147	7	29778605
Pubmed	Syntrophin-dependent expression and localization of Aquaporin-4 water channel protein.	DAG1 DMD	1.06e-04	4	147	2	11717465
Pubmed	A non-canonical function of Ezh2 preserves immune homeostasis.	EED ZBTB16	1.06e-04	4	147	2	28223321
Pubmed	Requirement of multiple basic helix-loop-helix genes for retinal neuronal subtype specification.	NEUROD4 NEUROD1	1.06e-04	4	147	2	15105417
Pubmed	Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.	DAG1 POMGNT1	1.06e-04	4	147	2	21129441
Pubmed	Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.	DAG1 DMD	1.06e-04	4	147	2	11259414
Pubmed	Dystroglycan is selectively associated with inhibitory GABAergic synapses but is dispensable for their differentiation.	DAG1 DMD	1.06e-04	4	147	2	12040032
Pubmed	The role of ADAMTS-2, collagen type-1, TIMP-3 and papilin levels of uterosacral and cardinal ligaments in the etiopathogenesis of pelvic organ prolapse among women without stress urinary incontinence.	ADAMTS2 TIMP3	1.06e-04	4	147	2	30388611
Pubmed	Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha.	INSR TIMP3	1.06e-04	4	147	2	16294222
Pubmed	Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.	NF1 METAP2	1.06e-04	4	147	2	16267007
Pubmed	Dystroglycan protein distribution coincides with basement membranes and muscle differentiation during mouse embryogenesis.	LAMA3 DAG1	1.06e-04	4	147	2	17676646
Pubmed	Plectin 1f scaffolding at the sarcolemma of dystrophic (mdx) muscle fibers through multiple interactions with beta-dystroglycan.	DAG1 DMD	1.06e-04	4	147	2	17389230
Pubmed	Requirement for Bhlhb5 in the specification of amacrine and cone bipolar subtypes in mouse retina.	NEUROD4 POU4F1 NEUROD1	1.40e-04	24	147	3	17092954
Pubmed	Identification of neuroglycan C and interacting partners as potential susceptibility genes for schizophrenia in a Southern Chinese population.	AMT DAG1 CDC25A PRODH	1.41e-04	62	147	4	19367581
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	ANK3 GIT1 PATZ1 ATG2B SHMT2 SNX33 CHORDC1 URGCP NF1 RPRD1A AMOTL1 UGGT2 PLEKHA7 CTSV SNRNP200 ZC3HAV1	1.56e-04	1321	147	16	27173435
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	EED NAGK ANK3 PATZ1 ARHGEF12 FAT1 NF1 KHDRBS1	1.59e-04	361	147	8	26167880
Pubmed	Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling.	INSR KHDRBS1	1.76e-04	5	147	2	11604231
Pubmed	Dp71 gene disruption alters the composition of the dystrophin-associated protein complex and neuronal nitric oxide synthase expression in the hypothalamic supraoptic and paraventricular nuclei.	DAG1 DMD	1.76e-04	5	147	2	22493004
Pubmed	Specific disruption of a schwann cell dystrophin-related protein complex in a demyelinating neuropathy.	DAG1 DMD	1.76e-04	5	147	2	11430802
Pubmed	Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.	INSR KHDRBS1	1.76e-04	5	147	2	12112020
Pubmed	Ten-eleven translocation (Tet) and thymine DNA glycosylase (TDG), components of the demethylation pathway, are direct targets of miRNA-29a.	TET2 TDG	1.76e-04	5	147	2	23820384
Pubmed	GIT1 utilizes a focal adhesion targeting-homology domain to bind paxillin.	GIT1 LPXN	1.76e-04	5	147	2	17467235
Pubmed	Expression of the dystrophin-glycoprotein complex is a marker for human airway smooth muscle phenotype maturation.	DAG1 DMD	1.76e-04	5	147	2	17993586
Pubmed	Regulation of Active DNA Demethylation through RAR-Mediated Recruitment of a TET/TDG Complex.	TET2 TDG	1.76e-04	5	147	2	28538185
Pubmed	Dystroglycan mediates homeostatic synaptic plasticity at GABAergic synapses.	DAG1 DMD	1.76e-04	5	147	2	24753587
Pubmed	Deficiency of the autophagy gene ATG16L1 induces insulin resistance through KLHL9/KLHL13/CUL3-mediated IRS1 degradation.	KLHL9 KLHL13	1.76e-04	5	147	2	31515271
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	HK1 GRK6 INSR ATG2B APBB1 DAG1 SLC30A6 NF1 USP6NL	1.77e-04	467	147	9	30194290
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	PITPNM2 ZBTB16 ANK3 KAT6A INSR LAMA3 XRCC2 KLHL9 ZNF544 TXNL4B RBM6 MAPK6 CATSPERG ALG12 MAN1B1 DOP1A ZC3HAV1	1.95e-04	1489	147	17	28611215
Pubmed	Agrin has a pathological role in the progression of oral cancer.	ANK3 NUP98 TRIM21 CKMT2 DMD SNRNP200	2.00e-04	197	147	6	29872149
Pubmed	Same but different - Molecular comparison of human KTI12 and PSTK.	ATG2B RAB3GAP1 AMOTL1	2.01e-04	27	147	3	33417976
Pubmed	A human MAP kinase interactome.	ZNF142 ANK3 NUP98 LAMA3 TRIM21 KHDRBS1 DMD MAPK6 SNRNP200	2.37e-04	486	147	9	20936779
Pubmed	An isoform of retinoid-related orphan receptor β directs differentiation of retinal amacrine and horizontal interneurons.	NEUROD4 POU4F1 NEUROD1	2.49e-04	29	147	3	23652001
Pubmed	Distinct effects of Hedgehog signaling on neuronal fate specification and cell cycle progression in the embryonic mouse retina.	NEUROD4 POU4F1 NEUROD1	2.49e-04	29	147	3	19474320
Pubmed	Fukutin-related protein associates with the sarcolemmal dystrophin-glycoprotein complex.	DAG1 DMD	2.63e-04	6	147	2	17452335
Pubmed	beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein.	GIT1 GRK6	2.63e-04	6	147	2	9826657
Pubmed	Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.	DAG1 POMGNT1	2.63e-04	6	147	2	22270369
Pubmed	Math3 and NeuroD regulate amacrine cell fate specification in the retina.	NEUROD4 NEUROD1	2.63e-04	6	147	2	11861467
Pubmed	Expression of the dystrophin-related protein 2 (Drp2) transcript in the mouse.	DAG1 DMD	2.63e-04	6	147	2	9245586
Pubmed	Interactions between dystrophin glycoprotein complex proteins.	DAG1 DMD	2.63e-04	6	147	2	7547961
Pubmed	Expression of dystroglycan, fukutin and POMGnT1 during mouse cerebellar development.	DAG1 POMGNT1	2.63e-04	6	147	2	12670716
Pubmed	miR-24 suppression of POZ/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) protects endothelial cell from diabetic damage.	ZBTB16 PATZ1	2.63e-04	6	147	2	27983982
Pubmed	Linc-YY1 promotes myogenic differentiation and muscle regeneration through an interaction with the transcription factor YY1.	EED DMD	2.63e-04	6	147	2	26658965
Pubmed	neurogenins, a novel family of atonal-related bHLH transcription factors, are putative mammalian neuronal determination genes that reveal progenitor cell heterogeneity in the developing CNS and PNS.	NEUROD4 NEUROD1	2.63e-04	6	147	2	9000438
Pubmed	Cessation of HIV-1 transcription by inhibiting regulatory protein Rev-mediated RNA transport.	NUP98 KHDRBS1	2.63e-04	6	147	2	19149559
Pubmed	Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.	ARHGEF12 PLCE1	2.63e-04	6	147	2	16565089
Pubmed	Contribution of the different modules in the utrophin carboxy-terminal region to the formation and regulation of the DAP complex.	DAG1 DMD	2.63e-04	6	147	2	10767429
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF142 ZBTB16 ZNF559 PATZ1 ZNF184 ZNF224 ZNF599 ZNF630 ZNF182 ZNF544 ZNF69 ZSCAN2 ZNF439 ZNF564 ZNF583 ZNF433 ZNF292	3.30e-07	718	99	17	28
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1	TET2 PAMR1 ADAMTS2 DDR2 ATG2B PRORSD1P LCAT PTER PXK ZNF182 FAT1 KCNA6 SLC26A7 P3H2 UGGT2 NEIL3 DMD SLITRK6 ZNF583 ADGRL3 DOP1A FILIP1L	9.96e-06	1166	142	22	facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 PAMR1 DDR2 FAT1 ACSM3 KLHL13 DMD SLITRK6 TNXB TBX5	1.18e-09	200	145	10	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	PAMR1 PDGFRL DDR2 FAT1 ACSM3 KLHL13 DMD SLITRK6 TNXB TBX5	1.18e-09	200	145	10	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 PAMR1 PDGFRL DDR2 ACSM3 KLHL13 DMD TNXB TBX5	1.04e-08	185	145	9	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 PAMR1 DDR2 FAT1 KLHL13 DMD SLITRK6 TNXB TBX5	1.95e-08	199	145	9	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ANK3 PDGFRL DDR2 FAT1 ACSM3 DMD SLITRK6 TNXB TBX5	2.04e-08	200	145	9	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PAMR1 PDGFRL DDR2 FAT1 ACSM3 DMD SLITRK6 TNXB TBX5	2.04e-08	200	145	9	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LA-01._Fibroblast_I\|LA / Chamber and Cluster_Paper	ZBTB16 PAMR1 PDGFRL DDR2 ACSM3 TIMP3 UGGT2 TNXB	1.34e-07	179	145	8	dcb6ec9ae72b13fe388b72dace2815293fafe8ee
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 PATZ1 ZNF184 PIPOX KCNA6 SLITRK6 ADGRL3 PLCE1	1.40e-07	180	145	8	da723df348d7b8449bb1124f23fe6fa706412adb
ToppCell	droplet-Heart-nan-3m-Neuronal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 PATZ1 ZNF184 PIPOX KCNA6 SLITRK6 ADGRL3 PLCE1	1.40e-07	180	145	8	5b146a94708b3c3610542a4d0925f3f7a2b19185
ToppCell	droplet-Heart-nan-3m-Neuronal-cardiac_neuron\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 PATZ1 ZNF184 PIPOX KCNA6 SLITRK6 ADGRL3 PLCE1	1.40e-07	180	145	8	50758b1e7be2e43f83c10ab106900c067e61f5f7
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 PAMR1 PDGFRL DDR2 KLHL13 DMD TNXB TBX5	1.73e-07	185	145	8	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 PAMR1 PDGFRL ACSM3 KLHL13 DMD SLITRK6 TBX5	1.96e-07	188	145	8	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	PDGFRL FAT1 ACSM3 KLHL13 DMD SLITRK6 FILIP1L TBX5	3.14e-07	200	145	8	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ANK3 PAMR1 FAT1 ACSM3 KLHL13 DMD SLITRK6 TBX5	3.14e-07	200	145	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FAT1 ACSM3 KLHL13 DMD SLITRK6 TNXB FILIP1L TBX5	3.14e-07	200	145	8	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PAMR1 PDGFRL KLHL13 DMD SLITRK6 TNXB TBX5	2.04e-06	179	145	7	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRL ADAMTS2 FAT1 ST8SIA6 TIMP3 PLEKHA7 USP6NL	2.20e-06	181	145	7	35eefd874a892eaf21f24fdce89e7ea3b8ee285f
ToppCell	facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRL ADAMTS2 FAT1 ST8SIA6 TIMP3 PLEKHA7 USP6NL	2.20e-06	181	145	7	e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968
ToppCell	21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high\|Trachea / Age, Tissue, Lineage and Cell class	PAMR1 PDGFRL ADAMTS2 DDR2 CKMT2 MYRF TNXB	2.28e-06	182	145	7	354dcdb01360597f68c4fe157a682aee1c0b8bb1
ToppCell	LA-01._Fibroblast_I\|World / Chamber and Cluster_Paper	PAMR1 PDGFRL DDR2 ACSM3 TIMP3 UGGT2 TNXB	2.73e-06	187	145	7	4ea486991f66c29728d127171a07b81404ec0b78
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 ADAMTS2 FAT1 P3H2 KLHL13 TNXB HMGCLL1	2.92e-06	189	145	7	1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 ADAMTS2 FAT1 P3H2 KLHL13 TNXB HMGCLL1	2.92e-06	189	145	7	bfb1c183a8a2752a2368b74150e66181c6a9da48
ToppCell	facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 ADAMTS2 FAT1 P3H2 KLHL13 TNXB HMGCLL1	2.92e-06	189	145	7	14833feea8f80744a06ece73f813eaeff8c4dd61
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADAMTS2 DDR2 KAT6A ARHGEF12 AMOTL1 ADGRL3 FILIP1L	3.03e-06	190	145	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ZBTB16 PAMR1 DDR2 ACSM3 UGGT2 TNXB ADGRL3	3.03e-06	190	145	7	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDGFRL DDR2 SLITRK6 TNXB HMGCLL1 ADGRL3 PLCE1	3.13e-06	191	145	7	5271198116343c07202649889057e5774d7fdde3
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	ZBTB16 PAMR1 DDR2 ACSM3 UGGT2 TNXB ADGRL3	3.13e-06	191	145	7	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	ZBTB16 PAMR1 DDR2 ACSM3 TIMP3 UGGT2 ADGRL3	3.13e-06	191	145	7	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PAMR1 PDGFRL ADAMTS2 DDR2 SLC26A7 KLHL13 TNXB	3.24e-06	192	145	7	8d56e360ebc624ca4cd7f0af4f3cc599c244f134
ToppCell	Mesenchymal-matrix_fibroblast_2_cell\|World / Lineage, Cell type, age group and donor	PAMR1 PDGFRL ADAMTS2 DDR2 SLC26A7 KLHL13 TNXB	3.24e-06	192	145	7	a769158c49d2b208c4224d85e7ae68c85cc372ed
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	ZBTB16 PAMR1 DDR2 ACSM3 TIMP3 UGGT2 TNXB	3.47e-06	194	145	7	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PAMR1 PDGFRL ADAMTS2 DDR2 SLC26A7 KLHL13 ADGRL3	3.47e-06	194	145	7	439d3f17c1f4736122b330e98add9292c7036a8e
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	ZBTB16 PAMR1 DDR2 ACSM3 TIMP3 UGGT2 TNXB	3.47e-06	194	145	7	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	facs-Lung-nan\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB16 PAMR1 PDGFRL ADAMTS2 DDR2 DAG1 PLCE1	3.72e-06	196	145	7	b05f77f3990b662682ffeaf0e4c2fb190e0a6e65
ToppCell	facs-Lung-nan-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB16 PAMR1 PDGFRL ADAMTS2 DDR2 DAG1 PLCE1	3.72e-06	196	145	7	787c6cd92035e0b1108c2c086c42a229016e476b
ToppCell	PND14-Mesenchymal\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 DMD FILIP1L TBX5	3.84e-06	197	145	7	9a14bc2e7d6081e2ab0e2e5555fc8804f13d3dbe
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 DMD FILIP1L TBX5	3.84e-06	197	145	7	8c728cd3c0382c4f3e4b78647b6e1447bb40ace1
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 ADGRL3 FILIP1L TBX5	3.97e-06	198	145	7	b2d295e330772bd8e24da356c75564b4297ea9c5
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 ADGRL3 FILIP1L TBX5	3.97e-06	198	145	7	ce59ee3d970397eb62d6387699c6c6cd65457898
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 ADGRL3 FILIP1L TBX5	3.97e-06	198	145	7	3ffaea4b44067d69f954b2bd3119c88a55ab232a
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FAT1 ACSM3 KLHL13 DMD TNXB FILIP1L TBX5	4.11e-06	199	145	7	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PAMR1 FAT1 ACSM3 DMD SLITRK6 TNXB TBX5	4.11e-06	199	145	7	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic\|Control_saline / Treatment groups by lineage, cell group, cell type	PAMR1 FAT1 KLHL13 DMD TNXB FILIP1L TBX5	4.25e-06	200	145	7	9d5b3c2dcfa55d50acc2ce2c319d51aa525d4cd1
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PAMR1 DDR2 FAT1 DMD SLITRK6 TNXB TBX5	4.25e-06	200	145	7	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ANK3 FAT1 ACSM3 KLHL13 DMD FILIP1L TBX5	4.25e-06	200	145	7	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	DDR2 FAT1 DMD SLITRK6 FILIP1L PLCE1 TBX5	4.25e-06	200	145	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	RV-16._Neuronal\|World / Chamber and Cluster_Paper	GINS3 ATP10B TIMP3 SLITRK6 ADGRL3 PRODH	9.49e-06	149	145	6	3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9
ToppCell	VE-CD8-naive_CD4\|VE / Condition, Cell_class and T cell subcluster	FADS6 ZNF224 NFS1 ZNF630 ACSM3 ZNF69	1.42e-05	160	145	6	255d2a150bfe19ee3d4d34533feb9c37ce73d225
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 FADS6 DMD TNXB FILIP1L	2.01e-05	170	145	6	fa753cc8fbd04e63c9a303da4dc17ee2ce907f92
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ADAMTS2 DDR2 FADS6 DMD TNXB FILIP1L	2.01e-05	170	145	6	03044e1436443b28dd39d5ef4fdb25c18e3a7546
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SNX33 MFSD14A TIMP3 ADGRL3 PRODH FILIP1L	2.21e-05	173	145	6	3001dd39244ef0a5a475d569a78f4ae427a55db6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SNX33 MFSD14A TIMP3 ADGRL3 PRODH FILIP1L	2.21e-05	173	145	6	c88883fb2a33e21d4201aa393674aa3f2ad780c9
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT1 AMOTL1 DMD SLITRK6 FILIP1L TBX5	2.85e-05	181	145	6	25915e2500430a902db37d79a749ce2990b69810
ToppCell	droplet-Kidney-nan-3m-Mesenchymal-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRL TDG KCNA6 SLITRK6 CATSPERG ZNF583	2.85e-05	181	145	6	0b1e7335648823b1d83bdfa878ccd44efe7bba9a
ToppCell	COVID-19-Endothelial_cells-Capillary_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	PITPNM2 ARHGEF12 ITPRID1 TIMP3 ARHGEF10 ADGRL3	2.85e-05	181	145	6	c5f9c92af1384d9089c65afdf41c6feb8345a3ae
ToppCell	PBMC-Control-cDC_12\|Control / Compartment, Disease Groups and Clusters	GINS3 GIT1 XRCC2 RRM1 CDC25A SLC29A4	2.94e-05	182	145	6	4774066d0f9986abc3d13a2a3bc99ce4f1327ae0
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PAMR1 PDGFRL DDR2 DMD SLITRK6 TNXB	3.04e-05	183	145	6	7eae9b3b4d1c9b135fa7cff348393d4adec474b4
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PDGFRL DDR2 DMD SLITRK6 TNXB TBX5	3.04e-05	183	145	6	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	AT1-AT2_cells-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	ZBTB16 LAMA3 TIMP3 P3H2 MYRF PLCE1	3.04e-05	183	145	6	6821dca076318115d360ff426eb1218cfe104063
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 ADAMTS2 DDR2 BEND2 DMD TNXB	3.13e-05	184	145	6	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PAMR1 PDGFRL ADAMTS2 DDR2 FILIP1L TBX5	3.23e-05	185	145	6	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	ZBTB16 ADAMTS2 TIMP3 TNXB HMGCLL1 TBX5	3.43e-05	187	145	6	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	droplet-Kidney-nan-18m-Epithelial\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK3 PTER TIMP3 MMUT IPMK PRODH	3.43e-05	187	145	6	236e9857729670e87eed30fad58f49e1f56e4a85
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PAMR1 PDGFRL DDR2 ACSM3 TNXB ADGRL3	3.53e-05	188	145	6	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	Control-Epithelial_cells\|Control / group, cell type (main and fine annotations)	ANK3 NBEAL1 LAMA3 P3H2 MAP3K13 PLEKHA7	3.53e-05	188	145	6	707ebf76cc6fb600b2f07793cf4ea9482c0de79d
ToppCell	facs-BAT-Fat-3m\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZBTB16 PDGFRL ADAMTS2 BIRC6 KLHL13 RBM6	3.64e-05	189	145	6	7ce71f9c81512ed38c804f025908746b4af3aab1
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR2 FAT1 KLHL13 DMD FILIP1L TBX5	3.64e-05	189	145	6	7ab1cfc1657277858339f7258a0c4ae9cb42fdf8
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro-stroma\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDGFRL DDR2 SLITRK6 TNXB HMGCLL1 PLCE1	3.64e-05	189	145	6	eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0
ToppCell	10x5'v1-week_14-16-Mesenchymal_fibro\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	PDGFRL DDR2 SLITRK6 TNXB HMGCLL1 PLCE1	3.64e-05	189	145	6	40764f461b8aa1d3a2c5a30590b7fb9307d47d09
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 PDGFRL DDR2 DMD TNXB HMGCLL1	3.75e-05	190	145	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 PDGFRL ADAMTS2 DDR2 TIMP3 TNXB	3.75e-05	190	145	6	97772e69e6f51ebffbb5433ca7b40f1048723220
ToppCell	droplet-Lung-nan-18m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PAMR1 PDGFRL ADAMTS2 DDR2 TIMP3 TNXB	3.75e-05	190	145	6	72c2b824acdc43139e6635785df3ed3feb58ec46
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	PAMR1 PDGFRL ADAMTS2 DDR2 TIMP3 FILIP1L	3.86e-05	191	145	6	9bbafdf316c1fa3a9f1ee30d41dd7158b5c97279
ToppCell	ASK440-Mesenchymal\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	PAMR1 PDGFRL ADAMTS2 DDR2 ABCC11 TIMP3	3.86e-05	191	145	6	f12959eebb4167e1aa03de05d7711a702c58b3c9
ToppCell	ASK440-Mesenchymal-Fibroblast\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	PAMR1 PDGFRL ADAMTS2 DDR2 ABCC11 TIMP3	3.86e-05	191	145	6	387296b5377ef6839f0812e5b3529a10b5f7d530
ToppCell	ASK454-Epithelial-Secretory\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	TBC1D2B ZNF224 NF1 RPRD1A ARHGEF10 RBM6	3.86e-05	191	145	6	c63c781e7e93265e591cf494cb4ce8ed797c24fb
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZBTB16 ADAMTS2 TIMP3 TNXB HMGCLL1 TBX5	3.86e-05	191	145	6	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-25\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAMR1 DDR2 ST3GAL2 KLHL13 IGSF1 TNXB	3.97e-05	192	145	6	30cefa0990ba1f379f350bfbf994a78db145075e
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR2 FAT1 KLHL13 DMD FILIP1L TBX5	3.97e-05	192	145	6	992d08092edbc68c47b945deb8708379738c239a
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 TIMP3 TNXB	3.97e-05	192	145	6	29bee88b45e23f16543ffc7cc361bc5da5d16a2b
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	PAMR1 DDR2 ACSM3 TIMP3 UGGT2 TNXB	3.97e-05	192	145	6	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZBTB16 ADAMTS2 TIMP3 TNXB HMGCLL1 TBX5	3.97e-05	192	145	6	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	facs-Lung-3m-Mesenchymal\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PAMR1 PDGFRL ADAMTS2 DDR2 TIMP3 TNXB	3.97e-05	192	145	6	8df15085b35b86f39debd933284cb703c5dd63c2
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PAMR1 PDGFRL ADAMTS2 DDR2 TIMP3 TNXB	3.97e-05	192	145	6	cdc652dbfabe41b324fd85c1ed933d29fb73a49f
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	PXK ZNF182 ACSM3 KHDRBS1 ARHGEF10 IPMK	4.09e-05	193	145	6	08696a99309f5b088692ddac8cca35413b5e810d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 PDGFRL DDR2 TIMP3 DMD TNXB	4.09e-05	193	145	6	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZBTB16 ADAMTS2 DDR2 TIMP3 TNXB TBX5	4.09e-05	193	145	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	PAMR1 PDGFRL ADAMTS2 KLHL13 MYRF PLCE1	4.09e-05	193	145	6	adc9fc94f9ec686a417d08c0b8b7b7ab687afec0
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D231\|Adult / Lineage, Cell type, age group and donor	ADAMTS2 DDR2 TIMP3 TNXB HMGCLL1 TBX5	4.09e-05	193	145	6	ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PITPNM2 ZBTB16 KAT6A ARHGEF12 ARHGEF10 ADGRL3	4.09e-05	193	145	6	a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	ZBTB16 PAMR1 DDR2 ACSM3 UGGT2 TNXB	4.09e-05	193	145	6	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	DDR2 ACSM3 TIMP3 UGGT2 TNXB ADGRL3	4.21e-05	194	145	6	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZBTB16 ADAMTS2 TIMP3 TNXB HMGCLL1 TBX5	4.21e-05	194	145	6	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	facs-Heart-RA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDGFRL ADAMTS2 DDR2 TIMP3 P3H2 TNXB	4.21e-05	194	145	6	c422aeddb4e949a22f731da675bdf91dee86ba61
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 FAT1 P3H2 KLHL13 MAP3K13 PLEKHA7	4.21e-05	194	145	6	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	PAMR1 PDGFRL ADAMTS2 DDR2 CTSV FILIP1L	4.21e-05	194	145	6	5f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZBTB16 PAMR1 ADAMTS2 DDR2 KLHL13 TNXB	4.33e-05	195	145	6	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 ADAMTS2 DDR2 TIMP3 TNXB FILIP1L	4.33e-05	195	145	6	803f714d91f2d97ecbee8c15a5139fd9310f66c7
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PAMR1 ADAMTS2 DDR2 TIMP3 DMD FILIP1L	4.33e-05	195	145	6	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	PAMR1 DDR2 ACSM3 TIMP3 UGGT2 TNXB	4.33e-05	195	145	6	a78b605b49acd8c9d68716266ca269dafcd910b9
Disease	Duchenne muscular dystrophy (is_implicated_in)	DAG1 DMD	6.88e-05	3	142	2	DOID:11723 (is_implicated_in)
Disease	Attention deficit hyperactivity disorder	GIT1 ADGRL3 ZNF292	2.05e-04	24	142	3	C1263846
Disease	Duchenne muscular dystrophy (is_marker_for)	DAG1 DMD	2.28e-04	5	142	2	DOID:11723 (is_marker_for)
Disease	Perineurioma	EED NF1	2.28e-04	5	142	2	C0751691
Disease	Nerve Sheath Tumors	EED NF1	2.28e-04	5	142	2	C0206727
Disease	Peripheral Nerve Sheath Neoplasm	EED NF1	2.28e-04	5	142	2	C0751689
Disease	Schwannomatosis, Plexiform	EED NF1	2.28e-04	5	142	2	C0751374
Disease	attention deficit hyperactivity disorder (implicated_via_orthology)	GIT1 NF1 ADGRL3	3.27e-04	28	142	3	DOID:1094 (implicated_via_orthology)
Disease	parathyroid hormone-related protein measurement	GRK6 ADA2	3.41e-04	6	142	2	EFO_0020622
Disease	Abnormal muscle tone	HK1 ZNF292	3.41e-04	6	142	2	C0852413
Disease	Neurilemmoma	EED NF1	3.41e-04	6	142	2	C0027809
Disease	muscular atrophy (biomarker_via_orthology)	DAG1 DMD CTSV	3.64e-04	29	142	3	DOID:767 (biomarker_via_orthology)
Disease	metabolite measurement	ANK3 GRK6 DDR2 INSR SHMT2 PTER KYAT1 DMD MYRF PRODH	3.97e-04	560	142	10	EFO_0004725
Disease	body fat distribution	PITPNM2 ADAMTS2 POMGNT1 SLC26A7 RBM6 PLCE1	4.52e-04	202	142	6	EFO_0004341
Disease	glycine measurement	PDGFRL GRK6 INSR DAG1 METAP2	5.40e-04	137	142	5	EFO_0009767
Disease	dilated cardiomyopathy (implicated_via_orthology)	DAG1 TIMP3 DMD CTSV	6.12e-04	80	142	4	DOID:12930 (implicated_via_orthology)
Disease	muscular dystrophy-dystroglycanopathy type B1 (implicated_via_orthology)	DAG1 POMGNT1	6.32e-04	8	142	2	DOID:0050588 (implicated_via_orthology)
Disease	alpha-2-macroglobulin measurement	TET2 GRK6	6.32e-04	8	142	2	EFO_0020138
Disease	cholesteryl ester 16:0 measurement	AMT MYRF ADGRL3	6.93e-04	36	142	3	EFO_0010341
Disease	Ehlers-Danlos syndrome (is_implicated_in)	ADAMTS2 TNXB	8.10e-04	9	142	2	DOID:13359 (is_implicated_in)
Disease	vesicoureteral reflux	ARHGEF10 CATSPERG HMGCLL1	8.14e-04	38	142	3	EFO_0007536
Disease	retinitis pigmentosa (is_implicated_in)	HK1 POMGNT1 SNRNP200	1.02e-03	41	142	3	DOID:10584 (is_implicated_in)
Disease	sleep disorder (implicated_via_orthology)	INSR NF1	1.23e-03	11	142	2	DOID:535 (implicated_via_orthology)
Disease	Leukemia, Myelocytic, Acute	TET2 NUP98 POU4F1 XRCC2 NF1	1.53e-03	173	142	5	C0023467
Disease	Antihypertensive use measurement	DDR2 INSR LPXN RBM6 CDC25A PLCE1	1.83e-03	265	142	6	EFO_0009927
Disease	MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2K	DAG1 POMGNT1	2.01e-03	14	142	2	C1836373
Disease	alpha-Dystroglycanopathies	DAG1 POMGNT1	2.01e-03	14	142	2	C2936406
Disease	Fukuyama Type Congenital Muscular Dystrophy	DAG1 POMGNT1	2.01e-03	14	142	2	C0410174
Disease	Muscle eye brain disease	DAG1 POMGNT1	2.01e-03	14	142	2	C0457133
Disease	rostral middle frontal gyrus volume measurement	ADGB MAPK6	2.01e-03	14	142	2	EFO_0010328
Disease	Autosomal recessive limb-girdle muscular dystrophy	DAG1 POMGNT1	2.01e-03	14	142	2	cv:C2931907
Disease	Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies) Type A, 1	DAG1 POMGNT1	2.01e-03	14	142	2	C4284790
Disease	Walker-Warburg congenital muscular dystrophy	DAG1 POMGNT1	2.32e-03	15	142	2	C0265221
Disease	Monogenic diabetes	INSR NEUROD1	2.64e-03	16	142	2	C3888631
Disease	inosine measurement	ZBTB16 DMD	3.73e-03	19	142	2	EFO_0010503
Disease	myocardial infarction (implicated_via_orthology)	DAG1 LCAT TBX5	4.00e-03	66	142	3	DOID:5844 (implicated_via_orthology)
Disease	Headache, HbA1c measurement	NBEAL1 DDR2	4.55e-03	21	142	2	EFO_0004541, HP_0002315
Disease	muscular dystrophy (implicated_via_orthology)	DAG1 DMD	4.55e-03	21	142	2	DOID:9884 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
VQLNHMDDHTLPGKY	TDG	171	Q13569
RIHQTMHYQFDGKPE	C2orf42	371	Q9NWW7
MHYQFDGKPEPLVFH	C2orf42	376	Q9NWW7
MALTTGKHEGYVHFG	CATSPERG	361	Q6ZRH7
GMVSYHAHNSPVKFI	ARHGEF10	1201	O15013
SHVIQHPMYGAGHKF	BIRC6	3841	Q9NR09
HPMYGAGHKFRTLHL	BIRC6	3846	Q9NR09
GRHMLLFNAYSPVGH	ADGB	746	Q8N7X0
LHNGEYSQGKHGFTM	CTSV	61	O60911
YKMFHHTAILKPESG	ADGRL3	1031	Q9HAR2
MSPVSKTQEHGLFYG	AMOTL1	321	Q8IY63
GLFYGDQHPGMLHEM	AMOTL1	331	Q8IY63
HRISVMGKDFYSHIP	DOP1A	1426	Q5JWR5
MGKDFYSHIPVDSNH	DOP1A	1431	Q5JWR5
HKNGHYIIPQMADSL	GIT1	241	Q9Y2X7
LSYHKNNLHDPMSGG	APBB1	401	O00213
FFSGRVAKGHKMHYP	DMD	3341	P11532
LDYHGKHVSMDQGTL	ATG2B	1821	Q96BY7
HLNKFKGYMEHPDQT	ATP10B	246	O94823
HGYIKMFEIPAGARH	ADAMTS2	736	O95450
SHFNYPGGVAMQRLH	ALG12	366	Q9BV10
ENIKAYHSGEGHMPF	ARHGEF12	1301	Q9NZN5
AAPHDIGYVKQAMFH	NAGK	176	Q9UJ70
PMGTIDKFHYGTHYS	NBEAL1	2086	Q6ZS30
MINFYHGGLKGVAHL	RAB3GAP1	466	Q15042
LPDGGHLTHGYMSDV	SHMT2	166	P34897
KDSHLHIPMYLFLGS	OR5H8	51	P0DN80
ITPLHDAVMNGHYKV	ANKRD31	556	Q8N7Z5
TYVGHPVKMGVYITH	FAT1	51	Q14517
GKSHPFKPDATYHTM	POU4F1	71	Q01851
SYHMHPAGIILTKVG	NUP98	726	P52948
SHYMKNFDVGHVPIR	METAP2	381	P50579
LHHMKYEIEDGSTPN	LAMA3	726	Q16787
SLPDVVMNGDPKHHY	NFS1	336	Q9Y697
HLMKYPCNTFGKPHT	NEIL3	361	Q8TAT5
KYDHPLGFMVTHVTE	ITPRID1	561	Q6ZRS4
HAGGHGIEFAPMYKI	DDR2	106	Q16832
HHRPLQMSYGSGSVT	BEND2	71	Q8NDZ0
MYGLPDSSHVGKHEY	DAG1	561	Q14118
YVHGAMQSPSLHKLV	TSFM	216	P43897
DFGLARIMDPHYSHK	MAPK6	171	Q16659
YHMKYRDNTPTVLHG	ABCC11	1146	Q96J66
KMSEPHYGHAGTVYG	KLHL9	431	Q9P2J3
ISAMGYKFHPEHFVC	LPXN	341	O60711
NPITMQCIKHYVGHG	EED	176	O75530
HPTKYISSNMGDFLH	LRGUK	626	Q96M69
EEHIPYTHMNGGKKN	INSR	1356	P06213
GYPGKMASQFQIHHL	NUP37	271	Q8NFH4
EAKPHMESYNAGVKH	P3H2	206	Q8IVL5
DSHLHTPMYFVVGNL	OR9G9	51	P0C7N8
GQYTHKVYHVGMHIP	PITPNM2	56	Q9BZ72
DGTLYKLHPHFSRIM	HK1	861	P19367
GAQTPGAHHFMSEYL	MED26	501	O95402
CVPLSHQVAGHMYGK	IPMK	46	Q8NFU5
HMYGKDKVGILQHPD	IPMK	56	Q8NFU5
GVYHGLPASHMELAQ	MAN1B1	536	Q9UKM7
VLHETFPKHTFLMNG	MFSD14A	61	Q96MC6
MKYGGHGYSHILTNV	PTER	306	Q96BW5
YMADHLKKHSEGPSN	PATZ1	481	Q9HBE1
TGIASGMNYLHLHKI	MAP3K13	261	O43283
PSHHSYMNAAGVPKQ	KAT6A	1981	Q92794
TPHQHMSFILYKDGS	IGSF1	801	Q8N6C5
VAKMSEPHYGHAGTV	KLHL13	471	Q9P2N7
SYTFHHGITPGEMGT	KCNA6	231	P17658
KIHIHLGSPYMQAVA	FILIP1L	1061	Q4L180
GHSLHDYKEALMIPA	ADA2	331	Q9NZK5
AHVDAQTKMGYTPLH	ANK3	721	Q12955
QTKMGYTPLHVGCHY	ANK3	726	Q12955
VLHYSGNVSSPKHAM	ANK3	2541	Q12955
TEILMKNEGSYGGHH	HOXC11	111	O43248
HMGPDPQYVGKLHSN	CDH18	66	Q13634
GDPKYAHLNMDLHVF	KHDRBS1	216	Q07666
MHAAYGKPVFLIGHS	LCAT	191	P04180
TPLYDFHLAHGGKMV	AMT	36	P48728
LKFHIYHMGQAGFPE	GRK6	271	P43250
QISHYLMEFGGTPKH	OLAH	151	Q9NV23
FHYIKSHKEQPGRNM	FAM120B	116	Q96EK7
KMHHAYTNVVGLGDS	FADS6	141	Q8N9I5
YEGGHIKGAVNLHME	CDC25A	391	P30304
FGDLPMGYQHLHTQL	PAMR1	396	Q6UXH9
HNGYDPRVMKHTTDL	CKMT2	131	P17540
AHGSPKLVMETIHDY	MROH5	116	Q6ZUA9
ADHTEVMKGIHQYPG	HMGCLL1	131	Q8TB92
GTYMTKSTPVVHLHF	TAF5	771	Q15542
YHLDLGTKTHNLPAM	UPP2	41	O95045
PMGHTYGFIDLDSHA	RBM6	696	P78332
GQEILHCYGPHKSRM	SMYD4	566	Q8IYR2
NSPVHLQYSMYGHKT	SLITRK6	651	Q9H5Y7
VVDLHKMGPHFYGFG	GINS3	106	Q9BRX5
KMGPHFYGFGSQLLH	GINS3	111	Q9BRX5
DPFGHIILNSMHKYQ	TBX5	166	Q99593
VKAVYMGHPGIDIHT	PLCE1	941	Q9P212
ISPHITNVGEMKHYL	SLC25A51	21	Q9H1U9
HTYYSAHPGGITEKM	OVCH1	731	Q7RTY7
GHVMAKRVFDTYSPH	POMGNT1	141	Q8WZA1
YDGHQHISIASLPGM	KYAT1	221	Q16773
FLEGGHEKVYFHPMT	PRORSD1P	126	A6NEY8
GYMTHTVSAPSLHGK	PLEKHA7	636	Q6IQ23
HPADHQVYFGQLLGM	PRODH	516	O43272
HMTSHPVLSQYEGFQ	SNX33	316	Q8WV41
EHHGRYPSTGMLVLF	ST3GAL2	271	Q16842
KHGFHQMPKEYSQIL	ST8SIA6	366	P61647
ISPHITNVGEMKHYL	SLC25A52	21	Q3SY17
DMKRGFVYLQPHSEH	PDGFRL	226	Q15198
SDGQLHKPMYFFLSH	OR6Y1	56	Q8NGX8
YPKMTAHTHSSFGLG	ACSM3	241	Q53FZ2
CVYHSGVPIFHEGMK	CHORDC1	176	Q9UHD1
RESGGHHYVNMTLPV	UFSP2	136	Q9NUQ7
YVHKDGLNSTDHMVP	XIRP2	3096	A4UGR9
HAFLRLEKTGHMPNY	URGCP	801	Q8TCY9
FQSHMIRHTGDGPYK	ZNF564	296	Q8TBZ8
KLFSGPKHAMHGFFV	USP6NL	211	Q92738
GHEDYHMMAFQLGPT	UBFD1	266	O14562
SYLMLHQRGHTGEKP	ZNF182	471	P17025
SFTQHMRIHTGEKPY	ZNF599	381	Q96NL3
LIAHQGMHTGEKPYE	ZSCAN2	461	Q7Z7L9
AMIKHLRTHNGASPY	ZBTB16	616	Q05516
KFSHTGVEPYIHQKM	TRPM6	1631	Q9BX84
HIAEPNYGKLTSMHF	RRM1	711	P23921
TGSHMHLPFAGDIYS	RPRD1A	296	Q96P16
MLHGHSGFFPINYVE	SH3GL2	331	Q99962
TVGGLEPGHKYKMHL	TNXB	1426	P22105
GKHMKTAHPDQYAAF	ZNF292	1116	O60281
LMHSIGLGYHKDLQT	NF1	1161	P21359
DKGFPYGHLHASNVM	PXK	281	Q7Z7A4
DSYPMVLGAQHFHSG	TRIM21	326	P19474
FHGPEGTGKTEMLYH	XRCC2	46	O43543
GHQRLHTGEKPYMCT	ZNF630	476	Q2M218
YHQAHKATGGPLKNM	THYN1	181	Q9P016
DLLPYGFAIHHAGMT	SNRNP200	776	O75643
FGLNHGHTPYSSMLN	SLC30A6	411	Q6NXT4
YLVMHQRTHTGEKPF	ZNF544	646	Q6NX49
SIQRHVVMHSGDGPY	ZNF69	206	Q9UC07
HHKYPGTSIVFDMSL	SLC29A4	96	Q7RTT9
TGEYPGLMKVSYHHG	PIPOX	261	Q9P0Z9
GLMKVSYHHGNHADP	PIPOX	266	Q9P0Z9
HMETIEKGYCNPGIH	ZC3HAV1	551	Q7Z2W4
NGQHMKVDYGSPDHT	TXNL4B	86	Q9NX01
TFNPVAYQDHVGKMH	ZNF142	381	P52746
MAHHGYFQLKANPGA	UGGT2	1126	Q9NYU1
NLDMHQKVHTGERPY	ZNF224	526	Q9NZL3
PAIIYAIFGMGHHVA	SLC26A7	86	Q8TE54
FYQHKSMNEPKHGLA	TET2	1901	Q6N021
FKSHMQTHPGVKPYD	ZNF559	396	Q9BR84
HLQMHGRTHTGEKPY	ZNF433	576	Q8N7K0
MSEKLPRLHGHFEQY	TBC1D2B	806	Q9UPU7
LAQHQRSHTGEKPYM	ZNF583	451	Q96ND8
MKHSVPVLPHGDQQY	KIAA0586	696	Q9BVV6
GKAFNGPSTFIRHHM	ZNF184	396	Q99676
RGFTKMPHVQYIHTE	TIMP3	71	P35625
FVGYMEESGFLPHSH	TM9SF1	141	O15321
IQRHMVVHSGDGPYK	ZNF439	201	Q8NDP4
KHMPKFNSISISGYH	MMUT	251	P22033
YAAMGQGLVPTDLHH	MYRF	216	Q9Y2G1
YGTMDSSHVFHVKPP	NEUROD1	231	Q13562
MSYDSYPHHGIGTQL	NEUROD4	311	Q9HD90